Litigation Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. ALKEM LABORATORIES LIMITED (D.N.J. 2018)
✉ Email this page to a colleague
SUMITOMO DAINIPPON PHARMA CO., LTD. v. ALKEM LABORATORIES LIMITED (D.N.J. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-10-09 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-01-02 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 8,729,085; 8,883,794; 9,174,975; 9,259,423; 9,555,027; 9,815,827; 9,827,242; 9,907,794 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUMITOMO DAINIPPON PHARMA CO., LTD. v. ALKEM LABORATORIES LIMITED
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. ALKEM LABORATORIES LIMITED (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-10-09 | 1 | FDA ten patents for Latuda®. The listed patents are U.S. Patent Nos. 5,532,372, 8,729,085, 8,883,794…United States Patent Nos. 9,815,827 (the “’827 patent”) and 9,907,794 (the “’794 patent”) (collectively…the ’827 patent is attached hereto as Exhibit A. A true and accurate copy of the ’794 patent is attached… U.S. Patent No. 9,815,827 27. The ’827 patent, entitled “Agent for Treatment… ’827 patent. 29. Plaintiff Sunovion is the exclusive licensee to the ’827 patent in the | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
